Lee, Jeong Hee; Khee-Su, Bae; Lee, Joon Woo; In, Youngyong - In: Journal of Open Innovation: Technology, Market, and … 2 (2016) 21, pp. 1-10
to predict royalty-related data is derived using the attrition rate for the corresponding development phase of the drug … follows. <Drug Class: Anticancer activity candidates> Royalty Rate=9.997+0.063 ∗ Attrition Rate+1.655 ∗ Licensee …-front+Milestones)=2.909 - 0.006 ∗ Attrition Rate+0.306 ∗ Licensee Revenue - 0.74 ∗ TCT Median - 0.113 ∗ Market …